Quality Assurance Scheme Development Group

The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.

The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months.

The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).  

The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.

Members and external experts

Aliki Stathopoulou

Aliki Stathopoulou

Dr. Aliki Stathopoulou received her diploma from the Department of Biology, University of Crete, in 1994 and her PhD from the Medical School, University of Crete, in 2002.

From 2002 to 2006 she worked as a Postdoctoral Researcher in the Laboratory of Clinical Chemistry, University of Athens. During her PhD and post doctoral research she worked on the development and clinical evaluation of highly sensitive molecular diagnostic methods for the early detection of micro-metastasis in breast cancer. In recognition of this work, she received the Excellent Poster Award at the 18th International Congress of Clinical Chemistry and Laboratory Medicine in 2002 and the Avon Foundation-AACR International Scholar-in-Training Grant at the AACR 96th Meeting in 2005.

From 2003 to 2007 she was employed as Temporary Lecturer at the Laboratory of Clinical Biochemistry and Molecular Biology, Medical School, University of Athens.

She has 15 publications in Scientific Journals and more than 100 abstracts.

Since 2006 she has been working for the National Accreditation Body of Greece (ESYD) as Accreditation manager. Her main activities include assessments of testing laboratories according to ISO/IEC 17025:2005 and clinical laboratories according to ISO 15189:2012, as well as trainings and development of accreditation guidelines, relevant to healthcare. She has been appointed as the ESYD’s delegate for the European co-operation for Accreditation Healthcare WG and the contact person for all the issues concerning health care. Currently she is the Deputy Director of the Laboratories Accreditation Division and the Head of the Testing Laboratories Accreditation sector.

Declaration of interests